Biotech

All Articles

OS Therapies refiles $6M IPO to cash HER2 medicine, preclinical ADCs

.Operating system Therapies will certainly provide on the NYSE American sell exchange today using a ...

ALX's fizzling CD47 feedback cost delivers sell spiraling down

.ALX Oncology's stage 2 gastric cancer cells feedback cost has deteriorated. After seeing its CD47 b...

Ionis centers eye disease from aim ats of Roche-partnered possibility after data let down

.An Additional of Ionis Pharmaceuticals' essential midphase readouts has fallen short of requirement...

Biogen's chief executive officer mentioned no dangerous deals in 2023. He prepares to be daring

.While Biogen's pharma peers are actually searching for late-stage assets with little bit of threat,...

Instil refills pipe in $2B biobucks take care of ImmunOnco

.Instil Bio has been a biotech trying to find a pipeline after it scrapped its lead assets over the ...

Biogen bows out Denali Alzheimer's collab

.Biogen has actually returned legal rights to an early Alzheimer's illness plan to Denali Therapies,...

Takeda faucets new head people oncology organization-- Chutes &amp Ladders

.Welcome to this week's Chutes &amp Ladders, our summary of notable leadership hirings, shootings as...

Vertex, beaten by AATD once again, drops 2 properties on dispose of pile

.Vertex's try to alleviate an uncommon genetic health condition has actually attacked another proble...

Vir increases 3 T-cell engagers from Sanofi, gives up 25% of personnel

.Vir Biotechnology's second-quarter profits report had not been short of large updates. The firm wel...

Galapagos stops briefly CAR-T tissue treatment hearing over Parkinsonism scenario

.Galapagos has paused registration in a trial of a BCMA-directed CAR-T tissue therapy, pushing the b...